Analysts have set 12-month price targets for Beam Therapeutics, revealing an average target of $44.5, a high estimate of $74.00, and a low estimate of $28.00. This current average reflects an increase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results